The 5,000-year view of rates and the economic consequences
The Bank of America wants you to know that, "Interest rates haven’t been this low in 5,000 years. That’s right, 5,000 years. In the next 5,000 years...
IMP Monthly Report | September 2021
After a record-equalling 11 month winning streak, the Australian market finally succumbed to a sell-off as both Iron Ore prices and global Equity markets...
BY Corporate Advisory sets exceptional benchmark for Q1
BY Corporate Advisory celebrated an excellent start to the 2021/2022 year, raising $50m in new capital for ASX-listed and unlisted companies as Lead or...
FRP Capital
FRP Capital believes the appropriate commercial property investment trumps all investment types due to its high-yielding nature, secure cash flow, and...
RedEarth Energy Storage Ltd
Homegrown renewables company, RedEarth Energy Storage Ltd, provides Australia’s only domestically-built energy storage solutions for residential, commercial
IMP Monthly Report | August 2021
August was yet another positive month for both the Australian share market (with the S&P/ASX 200 Index rising 1.92%) and global markets more broadly...
A boost for agriculture from SA
Leigh Creek Energy (ASX:LCK) is developing its flagship Leigh Creek Urea Project (LCUP), located 550km north of Adelaide in South Australia. The $2.6b...
At the core of nutrition
Nutritional Growth Solutions has a three-pillar growth strategy; new products, new territories, and new sales channels, which it has done via...
Corporate Travel Management Limited
After establishing a leading role in Australia’s business travel market, CTD has taken advantage of its relatively strong balance sheet and superior...
Radiopharm raises $20m for world-class nuclear medicine tech
Many of you will be familiar with Paul Hopper's name through successful biotechs such as Viralytics & Chimeric Therapeutics. He has a knack for discovering
IMP Monthly Report | July 2021
The Australian share market rose 1.09% in July, extending its remarkable rally to a 10th consecutive month, equalling its longest winning streak in 52 years
Paradigm: Investigative New Drug (IND) update
Paradigm is very close to IND approval, however, there remains uncertainty around when the company can expect to be given the green light...
BUY | Imugene Limited
We feel the attractively priced $95m raising gives IMU the funding it needs to progress and potentially even look at other opportunities...
BUY | MA Financial Group Ltd
MAF management and employees have plenty of skin in the game, led by Founder and MD Jason Pridham (28% shareholder) and US parent Moelis (20%)...
NGS: Reaching for new heights
Nutritional Growth Solutions is experiencing a significant period of growth, recently reporting record quarterly revenue of US$1.03m...
Global leader in child cyber safety with pure growth potential
With a large proportion of the world working, studying, and schooling from home, Family Zone Cyber Safety Ltd was in the right place at the right time...
A cutting edge oncology company
Given the demand of Chimeric’s primary asset, chlorotoxin, and its star-studded management team, the company’s share price shortly after listing reached...
10 franked income stock ideas for Australian investors
Morningstar's fair value estimates exclude the value of franking credits because they only have value to Australian resident taxpayers. However, franking...